Selective activation of TACI by syndecan-2

61Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

B-lymphocyte homeostasis and function are regulated by complementary actions of the TNFR family members TACI, BCMA, and BAFF-R, which are expressed by mature B cells. How these receptors are differentially activated is not entirely understood, because the primary ligand BAFF binds to all three. We searched for alternative ligands for TACI using recombinant TACI-Fc fusion protein as a probe and identified syndecan-2 as a new binding partner. TACI binding appears to require heparan sulfate posttranslational modifications of syndecan-2, because free heparin or pretreatment with heparitinase blocked the interaction. Syndecan-2 bound TACI but bound neither BAFF-R nor BCMA. Transfected cells expressing syndecan-2 activated signaling through TACI, as indicated by an NFAT-specific reporter. Syndecan-1 and syndecan-4 were also able to induce TACI signaling in a similar manner. This is the first identification of ligands that selectively activate TACI without simultaneously triggering BCMA or BAFF-R. This finding may help explain the alternative outcomes of signaling from this family of receptors in B cells. © 2006 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Bischof, D., Elsawa, S. F., Mantchev, G., Yoon, J., Michels, G. E., Nilson, A., … Bram, R. J. (2006). Selective activation of TACI by syndecan-2. Blood, 107(8), 3235–3242. https://doi.org/10.1182/blood-2005-01-0256

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free